ReviewJournal of clinical psychopharmacology

Central Nervous System Trial Failures: Using the Fragile X Syndrome-mGluR5 Drug Target to Highlight the Complexities of Translating Preclinical Discoveries Into Human Trials.

Margaret C Grabb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.